参考文献/References:
[1]Wei Y,Xia W,Ye X,et al.The antimicrobial protein short palate, lung, and nasal epithelium clone 1（SPLUNC1）is differentially modulated in eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps[J].J Allergy Clin Immunol,2014, 133(2):420-428. [2]王成硕,娄鸿飞,孟一帆,等.组织嗜酸粒细胞增多对慢性鼻-鼻窦炎伴鼻息肉复发的预测价值研究[J].中华耳鼻咽喉头颈外科杂志,2016,51(4):268-272. [3]Cao PP,Wang ZC,Schleimer RP,et al.Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes[J].Annals of allergy,asthma&immunology,2019, 122(1):33-40. [4]Oray M,Abu Samra K,Ebrahimiadib N,et al.Long-term side effects of glucocorticoids[J].Expert Opinion on Drug Safety,2016,15(4):457-465. [5]Wang X,Zhang N,Bo M,et al.Diversity of TH cytokine profiles in patients with chronic rhinosinusitis:A multicenter study in Europe,Asia,and Oceania[J].J Allergy Clin Immunol,2016,138(5):1344-1353. [6]Deconde AS,Mace JC,Levy JM,et al.Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis[J].The Laryngoscope,2017,127(3):550-555. [7]Bachert C,Zhang L,Gevaert P.Current and future treatment options for adult chronic rhinosinusitis:Focus on nasal polyposis[J].J Allergy Clin Immunol,2015,136(6):1431-1440. [8]Aoyagi T,Newstead MW,Zeng X,et al.IL-36 receptor deletion attenuates lung injury and decreases mortality in murine influenza pneumonia[J].Mucosal Immunology,2017,10(4):1043-1055. [9]German B,Wei R,Hener P,et al.Disrupting the IL-36 and IL-23/IL-17 loop underlies the efficacy of calcipotriol and corticosteroid therapy for psoriasis[J].JCI Insight,2019,4(2). [10]Bassoy EY,Towne JE,Gabay C.Regulation and function of interleukin-36 cytokines[J]. Immunological Reviews,2018,281(1):169-178. [11]Joo YH,Kim HK,Hak Choi I,et al.Increased expression of interleukin 36 in chronic rhinosinusitis and its contribution to chemokine secretion and increased epithelial permeability[J].Cytokine,2019(125):154798. [12]Henry CM,Sullivan GP,Clancy DM,et al.Neutrophil-Derived Proteases Escalate Inflammation through Activation of IL-36 Family Cytokines[J].Cell Reports,2016,14(4):708-722. [13]Wang H,Li ZY,Jiang WX,et al.The activation and function of IL-36gamma in neutrophilic inflammation in chronic rhinosinusitis[J].J Allergy Clin Immunol,2018,141(5):1646-1658. [14]Pothoven KL,Norton JE,Suh LA,et al.Neutrophils are a major source of the epithelial barrier disrupting cytokine oncostatin M in patients with mucosal airways disease[J].J Allergy Clin Immunol,2017,139(6):1966-1978,e9. [15]Pothoven KL,Norton JE,Hulse KE,et al.Oncostatin M promotes mucosal epithelial barrier dysfunction,and its expression is increased in patients with eosinophilic mucosal disease[J]. J Allergy Clin Immunol,2015,136(3):737-746,e4. [16]Tian T,Zi X,Peng Y,et al.H3N2 influenza virus infection enhances oncostatin M expression in human nasal epithelium[J].Experimental Cell Research,2018,371(2):322-329. [17]Schleimer RP.Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis[J].Annual Review of Pathology,2017(12):331-357. [18]Agarwal A,Spath D,Sherris DA,et al.Therapeutic Antibodies for Nasal Polyposis Treatment: Where Are We Headed[J].Clinical Reviews in Allergy&Immunology,2019. [19]Oliveria JP,Salter BM,Maclean J,et al.Increased IgE(+)B Cells in Sputum,but Not Blood,Bone Marrow,or Tonsils,after Inhaled Allergen Challenge in Subjects with Asthma[J].Am J Respir Crit Care Med,2017,196(1):107-109. [20]Dougan M,Dranoff G,Dougan SK.GM-CSF, IL-3,and IL-5 Family of Cytokines:Regulators of Inflammation[J].Immunity,2019,50(4):796-811. [21]Hassani M,Koenderman L.Immunological and hematological effects of IL-5(Ralpha)-targeted therapy:An overview[J].Allergy,2018,73(10):1979-1988. [22]Shin HW,Kim DK,Park MH,et al.IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis[J].J Allergy Clin Immunol,2015,35(6):1476-1485,e7. [23]Han M,Rajput C,Hong JY,et al.The Innate Cytokines IL-25,IL-33,and TSLP Cooperate in the Induction of Type 2 Innate Lymphoid Cell Expansion and Mucous Metaplasia in Rhinovirus-Infected Immature Mice[J].Journal of Immunology,2017,199(4):1308-1318. [24]Von Moltke J,Ji M,Liang HE,et al.Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit[J].Nature,2016,529(7585):221-225. [25]Vannella KM,Ramalingam TR,Borthwick LA,et al.Combinatorial targeting of TSLP,IL-25,and IL-33 in type 2 cytokine-driven inflammation and fibrosis[J].Science Translational Medicine,2016,8(337):337ra365. [26]Lam EP,Kariyawasam HH,Rana BM,et al.IL-25/IL-33-responsive TH2 cells characterize nasal polyps with a default TH17 signature in nasal mucosa[J].J Allergy Clin Immunol,2016, 137(5):1514-1524. [27]Zhao J,Maskrey B,Balzar S,et al.Interleukin-13-induced MUC5AC is regulated by 15-lipoxygenase 1 pathway in human bronchial epithelial cells[J].Am J Respir Crit Care Med,2009,179(9):782-790. [28]Reynolds JM,Lee YH,Shi Y,et al.Interleukin-17B Antagonizes Interleukin-25-Mediated Mucosal Inflammation[J].Immunity,2015,42(4):692-703. [29]Li Z,Zeng M,Deng Y,et al.15-Lipoxygenase 1 in nasal polyps promotes CCL26/eotaxin 3 expression through extracellular signal-regulated kinase activation[J].J Allergy Clin Immunol,2019,144(5):1228-1241.e1229. [30]Sastre J,Davila I.Dupilumab:A New Paradigm for the Treatment of Allergic Diseases[J].Journal of Investigational Allergology&Clinical Immunology,2018,28(3):139-150. [31]Bachert C,Mannent L,Naclerio RM,et al.Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis:A Randomized Clinical Trial[J].JAMA, 2016,315(5):469-479. [32]Bachert C,Han JK,Desrosiers M,et al.Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps(LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52):results from two multicentre,randomised,double-blind,placebo-controlled,parallel-group phase 3 trials[J].Lancet,2019,394(10209):1638-1650. [33]Carroll-Portillo A,Cannon JL,Te Riet J,et al.Mast cells and dendritic cells form synapses that facilitate antigen transfer for T cell activation[J].The Journal of Cell Biology,2015,210(5):851-864. [34]Matucci A,Vultaggio A,Maggi E,et al.Is IgE or eosinophils the key player in allergic asthma pathogenesis?Are we asking the right question[J].Respiratory Research,2018,19(1):113. [35]Bachert C,Sousa AR,Lund VJ,et al.Reduced need for surgery in severe nasal polyposis with mepolizumab:Randomized trial[J].J Allergy Clin Immunol,2017,140(4):1024-1031,e4. [36]Hashimoto S,Bel EH.Targeting IL-5 in severe asthma:a DREAM come true[J].Lancet,2012,380(9842):626-627.
相似文献/References:
[1]刘 娜,马庆杰,金 华.不同抗凝剂自体血回输对输卵管妊娠破裂患者炎症因子的影响[J].医学信息,2018,31(04):59.[doi:10.3969/j.issn.1006-1959.2018.04.019]
LIU Na,MA Qing-jie,JIN Hua.Effect of Different Anticoagulants Autologous Blood Transfusion on the Inflammatory Factors in Patients with Ruptured Tubal Pregnancy[J].Medical Information,2018,31(04):59.[doi:10.3969/j.issn.1006-1959.2018.04.019]
[2]毛红岩.冠状动脉介入治疗冠心病的疗效及
对患者血清炎症因子的影响[J].医学信息,2018,31(10):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
MAO Hong-yan.Effect of Coronary Intervention on Coronary Heart Disease and its Influence on Serum Inflammatory Factors[J].Medical Information,2018,31(04):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
[3]张东霞,李文超,白雨昕.腹腔镜下异位妊娠病灶清除术的治疗效果及对患者炎性反应指标和术后恢复的影响[J].医学信息,2022,35(11):121.[doi:10.3969/j.issn.1006-1959.2022.11.031]
ZHANG Dong-xia,LI Wen-chao,BAI Yu-xin.Effect of Laparoscopic Removal of Ectopic Pregnancy and its influence on Inflammatory Response Indexes and Postoperative Recovery[J].Medical Information,2022,35(04):121.[doi:10.3969/j.issn.1006-1959.2022.11.031]
[4]方海东,李 荣.血液透析滤过联合血液透析治疗慢性肾功能衰竭的效果观察[J].医学信息,2019,32(02):129.[doi:10.3969/j.issn.1006-1959.2019.02.037]
FANG Hai-dong,LI Rong.Effect of Hemodiafiltration Combined with Hemodialysis on Chronic Renal Failure[J].Medical Information,2019,32(04):129.[doi:10.3969/j.issn.1006-1959.2019.02.037]
[5]赵殿儒,祁景蕊.不同剂量瑞舒伐他汀对急性冠脉综合征患者心功能和炎症因子的影响[J].医学信息,2019,32(01):148.[doi:10.3969/j.issn.1006-1959.2019.01.046]
ZHAO Dian-ru,YAN Jing-rui.Effects of Different Doses of Rosuvastatin on Cardiac Function and Inflammatory Factors in Patients with Acute Coronary Syndrome[J].Medical Information,2019,32(04):148.[doi:10.3969/j.issn.1006-1959.2019.01.046]
[6]沈有录,卢红涛,刘维军.阿托伐他汀和瑞舒伐他汀对高海拔地区PCI患者血脂、炎症因子和血管内皮功能的影响[J].医学信息,2019,32(06):67.[doi:10.3969/j.issn.1006-1959.2019.06.022]
SHEN You-lu,LU Hong-tao,LIU Wei-jun.Effects of Atorvastatin and Rosuvastatin on Blood Lipids,Inflammatory Factors and Vascular Endothelial Function in Patients with High Altitude PCI[J].Medical Information,2019,32(04):67.[doi:10.3969/j.issn.1006-1959.2019.06.022]
[7]张 毅.替格瑞洛对不稳定型心绞痛患者PCI术后缺血事件及炎症因子水平的影响[J].医学信息,2022,35(13):130.[doi:10.3969/j.issn.1006-1959.2022.13.030]
ZHANG Yi.Effect of Ticagrelor on Ischemic Events and Inflammatory Factors in Patients with Unstable Angina Pectoris After PCI[J].Medical Information,2022,35(04):130.[doi:10.3969/j.issn.1006-1959.2022.13.030]
[8]褚春沐.丁苯酞序贯治疗对急性进展性脑梗死患者神经功能、炎症因子及Hcy、NSE的影响[J].医学信息,2022,35(17):129.[doi:10.3969/j.issn.1006-1959.2022.17.035]
CHU Chun-mu.Effect of Butylphthalide Sequential Therapy on Neurological Function, Inflammatory Factors, Hcy and NSE in Patients with Acute Progressive Cerebral Infarction[J].Medical Information,2022,35(04):129.[doi:10.3969/j.issn.1006-1959.2022.17.035]
[9]党佳蓉,党琳慧,郭煦妍,等.糖尿病肾病的发病机制研究[J].医学信息,2022,35(17):161.[doi:10.3969/j.issn.1006-1959.2022.17.044]
DANG Jia-rong,DANG Lin-hui,GUO Xu-yan,et al.Study on Pathogenesis of Diabetic Nephropathy[J].Medical Information,2022,35(04):161.[doi:10.3969/j.issn.1006-1959.2022.17.044]
[10]宋绪洋,孙 琰,刘 阳.剑突下胸腔镜手术在前纵隔肿瘤切除患者中的有效性和安全性分析[J].医学信息,2022,35(14):89.[doi:10.3969/j.issn.1006-1959.2022.14.020]
SONG Xu-yang,SUN Yan,LIU Yang.Effectiveness and Safety of Subxiphoid Thoracoscopy in Patients with Anterior Mediastinal Tumor Resection[J].Medical Information,2022,35(04):89.[doi:10.3969/j.issn.1006-1959.2022.14.020]